Show simple item record

Authordc.contributor.authorMoncada-Basualto, Mauricio 
Authordc.contributor.authorLapier, Michel 
Authordc.contributor.authorMaya Arango, Juan 
Authordc.contributor.authorMatsuhiro, Betty 
Authordc.contributor.authorOlea Azar, Claudio
Authordc.contributor.authorDelogu, Giovanna 
Authordc.contributor.authorUriarte, Eugenio 
Authordc.contributor.authorSantana, Lourdes 
Authordc.contributor.authorJoão Matos, María 
Admission datedc.date.accessioned2018-11-20T18:43:32Z
Available datedc.date.available2018-11-20T18:43:32Z
Publication datedc.date.issued2018
Cita de ítemdc.identifier.citationMedicinal Chemistry, 2018, Vol. 14(6), No. 00es_ES
Identifierdc.identifier.issn1573-4064
Identifierdc.identifier.other10.2174/1573406414666180419113437
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/152738
Abstractdc.description.abstractBackground: Neglected diseases are becoming more prevalent due to globalization. This has inspired active research in the development of new drugs for the treatment of parasitic diseases such as Chagas disease. Objectives: With the aim of finding new trypanocidal agents, we report the in vitro evaluation of a new series of 3-amidocoumarins with or without hydroxyl substituents at position 4 of the coumarin ring. Methods: Electrochemical and biological assays were performed in order to assess the antioxidant and trypanocidal potential of these compounds and to better understand the mechanisms involved in their activity. Results: Most of the studied compounds showed high trypanocidal activity against both epimastigote and trypomastigote forms, with IC50 values in the low micromolar range. Some of them have greater activity and selectivity than the reference compound, nifurtimox. Conclusion: Compound 2 is the most active of this series, being also non-cytotoxic against murine RAW 264.7 macrophages. Electrochemical and radical scavenging experiments were carried out, providing new information about the profile of the best derivatives, and the potential therapeutic application of the new 3-amidocoumarins.es_ES
Patrocinadordc.description.sponsorshipThe authors thank PhD fellowship from CONICYT, MMB grant for operational expenses (No 21150192), ML Post-PhD/FONDECYT No 3160022, JDM FONDECYT No 1130189, COA FONDECYT 1150175 and Postdoctoral fellowship from Xunta da Galicia (ED481B 2014/086-0).es_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherBentham Sciencees_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceMedicinal Chemistryes_ES
Keywordsdc.subject3-amidocoumarinses_ES
Keywordsdc.subjecttrypanosoma cruzies_ES
Keywordsdc.subjecttrypanocidales_ES
Keywordsdc.subjectantioxidantes_ES
Keywordsdc.subjectchagas diseasees_ES
Títulodc.titleEvaluation of trypanocidal and antioxidant activities of a selected series of 3-amidocoumarinses_ES
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorrvhes_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile